Preexisting and postbaseline resistance analyses in pooled pediatric studies of emtricitabine/tenofovir alafenamide-based antiretroviral therapy

ePoster:

• Preexisting and postbaseline resistance analyses in pooled pediatric studies of emtricitabine/tenofovir alafenamide-based antiretroviral therapy (IAS 2023 EPOSTER; Andreatta, et al)
• Electronic version of the scientific poster for IAS 2023 (Andreatta, et al.)

Poster supplement:

• Preexisting and postbaseline resistance analyses in pooled pediatric studies of emtricitabine/tenofovir alafenamide-based antiretroviral therapy (IAS 2023 SUPPLEMENT; Andreatta, et al)
• Supplementary data for the scientific poster for IAS 2023 (Andreatta, et al.) that describe pooled resistance analysis data from four pediatric studies of B/F/TAF, E/C/F/TAF and F/TAF plus third agent. The supplement contains additional data on study regimens, preexisting resistance, and virologic profiles of emergent resistance.

Email this presentation